Professor Roger Stupp MD 

 

Professor and Chairman, Department of Oncology & Director, University Hospital Cancer Center, University of Zurich, Zurich/Switzerland

Roger Stupp gained his MD at the University of Zurich. After training in oncology and hematology at the University of Chicago he spent 17 years as a physician and researcher at the University of Lausanne, Switzerland. Since 2013 he is the Director of the Department of Oncology and Cancer Center at the University Hospital in Zurich. He also serves as the President of the European Organisation for Research and Treatment of Cancer (EORTC), the prime cooperative group conducting clinical trials and translational research throughout a pan-European network of over 200 active universities and academic medical centers. Dr. Stupp's research focuses on early drug development, the combination of chemo- and radiotherapy, multidisciplinary cancer management, namely in the areas of lung cancer and brain tumors. He is involved in bringing new antiangiogenic and biological treatments to the clinic. Dr. Stupp is or has been the principal investigator for large multimodality clinical trials in brain tumors and non-small cell lung cancer. His work has been extensively published in such journals as The New England Journal of Medicine, Lancet Oncology, Clinical Cancer Research, Molecular Oncology, Neuro-Oncology, the European Journal of Cancer, and the Journal of Clinical Oncology, among others. (more...)
 

 

Head, Laboratory of Molecular Pathology, Ludwig Institute for Cancer Research, USA
Professor, University of California San Diego, USA

Paul Mischel’s research is directed at defining the signal transduction and metabolic networks that promote tumor growth, focusing primarily on EGFR/PI3K/mTOR signaling and its biochemical consequences. The Mischel group has a particular interest in glioblastoma, tightly integrating studies in pre-clinical models with analyses of patients treated in state of the art clinical trials, with the goal of developing more effective, less toxic therapies. Recently, his group has also become particularly interested in the role of extrachromosomal DNA in cancer.

Dr. Mischel received his M.D. with honors (Alpha Omega Alpha) from Cornell University Medical College. He did residency and fellowship training in Anatomic Pathology and Neuropathology at the University of California, Los Angeles and followed his clinical training with a post-doctoral research fellowship in the laboratory of Dr. Louis Reichardt, at the Howard Hughes Medical Institute at University of California San Francisco. Dr. Mischel joined the faculty of UCLA in 1998, becoming the Lya and Harrision Latta Professor of Pathology and Laboratory. In August of 2012, Dr. Mischel was recruited to the Ludwig Institute for Cancer Research, San Diego Branch. (more...)

 

 

Associate Professor of Radiation Oncology and Surgery, University of Toronto, Canada
Deputy Chief, Department of Radiation Oncology, Odette Cancer Centre, Canada

Arjun Sahgal is a leader in the field of high precision stereotactic radiation to the brain and spine. After training at the University of Toronto in radiation oncology, he completed a fellowship at the University of California San Francisco in brain and spine radiosurgery with Professor Dr. David Larson. Since then he has been recognized as a national and international clinical expert and research leader in radiosurgery. His main focus is on developing spine stereotactic body radiotherapy (SBRT) as an effective therapy for patients with spinal tumors. He has published numerous peer reviewed papers and book chapters on the subject. He has already published over 100 peer reviewed papers including high impact journals like Journal of Clinical Oncology and Lancet Oncology, editor and writer of several books specific to research on brain and bone metastases, editorial board member for several journals, past-chairman of the International Stereotactic Radiosurgery Society meeting held June 2013, and board member for the Brain Tumour Foundation of Canada and the International Stereotactic Radiosurgery Society. He has been invited internationally to speak at several meetings and to various universities as a visiting professor, and leads several research groups. His further research activities involve integrating MRI into radiotherapy delivery, combining novel pharmacologic therapies with radiosurgery, and MRI-Guided focused ultrasound.
 

 

W. K. Alfred Yung is professor and chair of Neuro-oncology at The University of Texas MD Anderson Cancer Center, where he holds the Margaret and Ben Love Chair of Clinical Cancer Care and dual appointment as professor of cancer biology. He is also a professor of neurology at the University of Texas (UT) Health Sciences Center at Houston Medical School and a faculty member at the UT Graduate School of Biomedical Sciences in Houston.

He earned his undergraduate degree from the University of Minnesota, Minneapolis and his medical degree from the University of Chicago Pritzker School of Medicine. Internship and residency training followed at the University of California, San Diego. He completed chief residency and a fellowship at Cornell University School of Medicine and Memorial Sloan-Kettering Cancer Center. Dr. Yung joined MD Anderson as assistant professor in 1981 and rose quickly through the faculty ranks. (more...)
 

Professor of Neurosurgery and Oncology, Johns Hopkins University School of Medicine, USA

Gregory Riggins is the inaugural Irving J. Sherman M.D. Research Professor of Neurosurgery and Oncology at Johns Hopkins University School of Medicine. He is the director of the Brain Cancer Biology and Therapy Laboratory at Johns Hopkins School of Medicine, started in 2003 and the director of the division of neurosurgery research.

The Brain Cancer Biology and Therapy Laboratory is a translational cancer research lab for brain and other cancers.  His laboratory has helped develop cancer therapies based on drug repurposing, drug combinations, novel targeted therapy, bacteria based immunotherapy, and cancer prevention. (more...)
 

 

Courtesy of Brain Tumour Alliance Australia

Assistant Adjunct Professor, UCSF School of Nursing, USA

Mary Lovely earned her PhD at the University of California San Francisco (UCSF) School of Nursing focusing on symptom management and brain tumor patient care.  During her Post Doctoral Fellowship she studied the effects of fatigue on brain tumor patients.

Dr. Lovely developed a program of research around long-term effects experienced by patients and families with brain tumors.  She has numerous presentations and publications as Assistant Adjunct Professor in the UCSF School of Nursing. (more...)
 

 

Professor of Palliative Medicine, Centre for Cardiovascular and Chronic Disease, University of Technology Sydney

Professor Meera Agar is a Palliative Medicine Physician and is the research lead for the South West Sydney Palliative Care Clinical Trials unit and the Clinical trials director, Ingham Institute of Applied Medical Research. Her research interests include delirium in advanced cancer, dementia end-of-life care, pharmacological and health service randomised controlled trials in palliative care and neuro-oncology supportive and palliative care research. She is the Chair of ImPACCT (Improving Palliative Care through Clinical Trials), the NSW collaborative trials group in palliative care.
 

 

Brian Alexander, MD, MPH, is a radiation oncologist specializing in research and clinical care for patients with tumors of the central nervous system, and is the Director of the Neuro-Radiation Oncology Program at the Brigham and Women’s/Dana-Farber Cancer Center. His research interests include the characterization of the radiation responsiveness of glioma stem cells, preclinical evaluation of novel therapeutics, and innovative designs for early phase clinical trials. (more...)

 

 

Tiara Aninditha, a Neuro-Oncologist consultant, is currently the Head of Neuro-Oncology, Headache, and Pain Division in Neurology Department, Faculty of Medicine University of
Indonesia.

 
Following completion of her residency at Neurology Department Faculty of Medicine University of Indonesia in 2006, she joined the medical staff in that university in 2007. Together with her professor, she established the Neuro-Oncology division in her department and running the Neuro-Oncology module, the first and the only Neurology residency program in Indonesia. (more...)

 

 

Dr. Barker is co-director of Complex Adaptive Systems at Arizona State University (ASU), which serves as an organizing construct to understand and solve multidimensional problems in the biomedical sciences and biomedicine. She develops knowledge networks that leverage convergent knowledge in the biological and physical sciences, innovative teams, and novel funding approaches to better prevent and treat acute and chronic diseases. (more...)

 

 

Clinical Associate Professor Head, Neurology ICU
Assistant Chair for Emergency Room Services
Neuro-Oncology Service
Department of Neurosciences
Philippine General Hospital, Manila, Philippines

Neurologist with subspecialty in Neuro-Oncology
St. Luke’s MEDICAL CENTER Quezon City and Bonifacio Global City, Philippines

President, Philippine Society for Neuro-Oncology Training

Neuro Oncology Fellowship: Johns Hopkins Medical Institutions, Baltimore, Maryland USA
Medical School: University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines Neurology Residency: University of the Philippines Philippine General Hospital, Manila, Philippines

Previous Positions/Work:
Head, Comprehensive Brain Tumor Center, St Luke’s Medical Center, Quezon City, Philippines

 

 

Dr. Berry is a professor in the Department of Biostatistics of The University of Texas MD Anderson Cancer Center. He was founding chair of this department in 1999 and founding head of the Division of Quantitative Sciences, including the Department of Bioinformatics and Computational Biology, in 2006. Dr. Berry received a PhD degree in statistics from Yale University and previously served on the faculties of the University of Minnesota and Duke University. He held endowed faculty positions at Duke University and at MD Anderson. (more...)

 

 

Vivien Biggs has over 25 years experience working in Neurosurgery in both Sydney and Brisbane. She has a Post-graduate certificate in Neuroscience Nursing and a Masters of Nursing Science (Nurse Practitioner). She has worked in both public and private practice and joined the Neurosurgical team at BrizBrain and Spine in 2007. The role was originally as a Care Coordinator for brain tumour patients and their families and from 2010 the role evolved to her current position as Neuro-Oncology Nurse Practitioner.

Vivien’s role also involves working with the research nurses at the Newro Foundation assisting with patient recruitment and assessment for their scientific and psychosocial research projects. She lectures to under graduate and post graduate nurses on Neurological Nursing at the Queensland University of Technology.

 

 

A/Professor Andrew Cole has been a Consultant in Rehabilitation Medicine and a conjoint UNSW academic since 1985, working as HammondCare’s Chief Medical Officer since 2008. He is President of the Australasian Faculty of Rehabilitation Medicine.
His interests lie in rehabilitation of cancer and neurological disability, and providing rehabilitation care for very frail older people, at Greenwich Hospital.

In Australia, Andrew teaches about disability and ageing to UNSW medical students and rehabilitation trainees. He has regularly taught these topics to medical, nursing and allied health staff during visits to East Asia in the last decade.

Andrew maintains life balance by spending time with his family members, playing classical organ music, learning Chinese, enjoying steam trains and doing practical jobs around the home and garden.

 

 

Dr. Dr. Cloughesy is a Professor of Neurology at the David Geffen School of Medicine at UCLA. He received his BA degree with Honors in Chemistry in 1983 at University of California, Santa Barbara, and his MD degree in 1987 at Tulane University. He completed his Neurology Residency at University of California, Los Angeles and fellowships in Clinical Neurophysiology (UCLA 1991- 1992) and Neuro-Oncology (Memorial Sloan Kettering Cancer Center 1992). (more...)

 

Ms Marcia Fleet is a Cancer Care Coordinator in the Neuro-Oncology unit at Royal Melbourne Hospital.

Trained as a radiation therapist and worked for many years in departments in Victoria and NSW. This  experience of many years in oncology works well with the care coordination position.

 
In the CCC position she works with the medical staff to support the patients and their families from before diagnosis often to end of life. She is the go to person within the unit and runs a support group for patients with high grade tumours.

 

Associate Professor Foote is a Radiation Oncologist at the Princess Alexandra Hospital, Brisbane.  He is a full time academic clinician (teaching and research) since his appointment as a Staff Specialist in 2010.

Associate Professor Foote established and is Co-director of the Gamma Knife® Centre of Queensland, the only public unit in Australia providing Gamma Knife® radiosurgery for brain tumours.  Having completed his advanced training in Radiation Oncology in 2009, Assoc Prof Foote commenced a neuro-oncology and stereotactic fellowship at the Princess Margaret Hospital, Toronto, Canada.  He now has an established clinical and translational research program with multiple national and international collaborations, serving as study chair on both national and international clinical studies.
 

Rakesh Jalali leads the Neuro-Oncology Group in TMH, finest and premier such unit in India drawing patient referral, training opportunities, observers and research project requests and funding. His research interests has focused on evaluation of high-precision techniques of radiotherapy, late-term toxicities and quality of life, biological imaging, molecular prediction and clinical evaluation of new agents in neuro-oncology. He has more than 200 publications to his credit. (more...)

Dr Ben Jonker is a neurosurgeon based in Sydney. He completed his neurosurgical training in Australia, and subsequently undertook subspecialty training in Stereotactic and Functional Neurosurgery (including stereotactic radiosurgery) in Calgary, Canada and UCLA, Los Angeles.
 
Dr Jonker has a particular interest in conditions treated with stereotactic and functional neurosurgery – and treats these with both conventional neurosurgery and stereotactic radiosurgery. His main interests are brain and pituitary tumours including awake surgery and brain mapping, trigeminal neuralgia, movement disorder surgery and endoscopic surgery for hydrocephalus.

 

Dr Mustafa Khasraw acts at the NHMRC Clinical Trials Centre of The University of Sydney as a senior research fellow and clinical lead for the Cooperative Trials Group for Neuro-Oncology (COGNO). In addition, Dr Khasraw is a medical oncologist at Royal North Shore Hospital and over the previous 5 years he worked in Geelong as a medical oncologist and cancer research fellow at Deakin University with leading role in several clinical and translational laboratory programs.

 
After his medical oncology training in Sydney he undertook an oncology fellowship training in the US at Memorial Sloan-Kettering Cancer Centre in New York. His fellowship was both in neuro-oncology and in breast cancer.

 
Mustafa Khasraw is leading several multi-centre clinical trials and he acts regularly as a reviewer for a number of scientific journals and grant review committees.

 

Dr Eng-Siew Koh is a consultant Radiation Oncologist based at Liverpool Cancer Therapy Centre, Liverpool Hospital, NSW. She qualified in Medicine at the University of Adelaide then completed her specialty training at Westmead Hospital. She undertook a three year Fellowship at the Princess Margaret Hospital, and the Hospital for Sick Children, University of Toronto, Canada, in the areas of adult and paediatric neuro-oncology and stereotactic radiotherapy, and also haematologic and breast malignancies.

Her clinical and research interests include neuro-oncology imaging, cognitive and behavioural sequelae in brain tumours, and clinical neuro-oncology care coordination. Dr Koh has a particular research interest in cancer survivorship and the study of late effects of cancer treatment in both adult and paediatric cancer patients, in particular, the induction of secondary malignancy. She is the current chair of the Clinical Oncological Society of Australia (COSA) Neuro-oncology group and is a member of the COGNO Scientific and Management Advisory Committees.

 

Dr Danette Langbecker is an NHMRC Research Fellow at the Centre for Online Health, The University of Queensland.  Her overall program of research to date has focused on investigating how best to support cancer patients and their families, with a focus on people affected by brain tumours. She completed a PhD at the Queensland University of Technology that involved developing and testing a patient-focused resource to encourage communication between health professionals and patients and families affected by brain tumours, and she continues to develop this program of research with colleagues in Australia and internationally.

Danette’s research within the COH focuses on the development and testing of an online intervention to improve self-efficacy to care and reduce caregiver burden and distress among family members of adults with primary brain tumours. Another stream of research focuses on understanding the impacts and supportive care needs of long term brain tumour survivors and their family members. Danette is also am supporting ongoing research in the COH in the areas of online health and telehealth, investigating applying new technologies to improve models of care for people with a range of conditions.
 

Dr. Giuseppe Minniti is a Professor of Radiation Oncology at Sant’Andrea Hospital, University of Rome “La Sapienza”. He is also a Honorary Neuro-oncology Consultant at IRCCS Neuromed and Scientific Consultant for Neuro-oncology at the University of Pittsburgh Medical Center (UPMC), San Pietro Hospital.

His main interests are brain tumors, chemotherapy and radiotherapy for primary and secondary brain tumors, stereotactic radiotherapy and radiosurgery. He has authored more than 130 publications on indexed international medical journals. He is a member of the European Society for therapeutic Radiology and Oncology (ESTRO), Italian Society of Radiotherapy (AIRO), Italian Society of Neurooncology (AINO), European Association of Neuro-Oncology (EANO) and European Organisation for Research and Treatment of Cancer (EORTC) – Brain Tumour Group.
 

Professor Anna Nowak is an academic Medical Oncologist at Sir Charles Gairdner Hospital in Western Australia, and Professor of Medicine in the School of Medicine and Pharmacology, University of Western Australia. Her clinical and research interests are in malignant pleural mesothelioma and neuro-oncology, with a PhD in tumor immunology and post-doctoral fellowship in clinical trials research giving her a niche as a ‘bench to bedside’ researcher who has implemented findings from her laboratory into first-in-man clinical trials. She has been a member of COGNO since its inception and her research in high grade glioma focuses on active participation in clinical trials and collaboration on psychosocial and supportive care research questions, as well as being co-chair of the AGOG tissue banking and genetic epidemiology project and the newly formed Brain Cancer Biobanking Australia.

 

In her association with COGNO, she is a member of the Scientific Advisory Committee, and is currently the Australian PI of the EORTC CATNON clinical trial, and Trial Management Committee Member of the completed CABARET study. She has been site principal investigator of numerous clinical trials in high grade glioma at Sir Charles Gairdner Hospital. Prof Nowak leads the neuro-oncology service at Sir Charles Gairdner Hospital, which sees around 130 new patients a year with glioma, and is committed to maximizing participation of these patients in clinical research.

 

Chief of MRI and CT department, Global Hospitals, Mumbai

It is a tertiary care hospital close to the largest Cancer Centre in India – Tata Memorial Hospital.
She has a special interest in Neuro-Onco-Radiology where she has dedicated more than 14 years, working closely with Disease Management Group led by Dr. Rakesh Jalali at Tata Memorial Hospital.

She has pioneered MR Spectroscopy, MR Perfusion and 3D Arterial Spin Labelling in India and trained in Grant Medical Hospital and Lokmanya Tilak Hospitals in  Mumbai.

She has also trained for MR Spectroscopy Services, with Dr Brian Ross, Pennysylvania.
A founding member of Indian Society of Neuro-oncology.
Currently the treasurer of Indian Society of Neuro-oncology.
Teaching experience for more than six years for Radiology students.
Several national and international lectures and publications.
Author of two chapters in text books.
Author for a Karl Storz publication on ENT.

 

 
Professor Mark Rosenthal trained as a Medical Oncologist in Melbourne and Sydney, Australia. He was awarded a Doctorate of Philosophy for a thesis examining the molecular genetics of colon cancer conducted at the Ludwig Institute for Cancer Research. (1992-1996).

He completed post-graduate training at New York University Medical Centre, New York, USA (1996-98) and was appointed as a Senior Staff Specialist in the Department of Medical Oncology, Royal Melbourne Hospital in 1998. In 2006, he was appointed Professor Director of the Department and was Chairman and Chief Medical Officer of Cancer Trials Australia until 2016 when he was appointed as Director of the Victorian Comprehensive Cancer Centre Clinical Trials Unit.

He is Chairman of the Cooperative Trials Group for Neuro-Oncology (COGNO). His major interests include: prostate cancer, neuro-oncology and early phase clinical trials.

 

Associate Professor of Medicine
Faculty of Medicine Siriraj Hospital
Mahidol University, Bangkok, Thailand

Sith Sathornsumetee, MD, is an Associate Professor of Medicine and Director of the Neuro-oncology Program in the Department of Medicine at the Faculty of Medicine Siriraj Hospital, Mahidol University, in Bangkok, Thailand.

Dr. Sathornsumetee received his medical degree from the Faculty of Medicine at Siriraj Hospital, Mahidol University. He completed his research training in neuro-immunology at Mayo Clinic College of Medicine in Rochester, Minnesota, and then his neurology residency and neuro-oncology fellowship at Duke University Medical Center in Durham, North Carolina, USA. (more...)

 

 
Timothy Solberg received his master of science degree in physics from the University of California, Davis, and his PhD in biomedical physics from the University of California, Los Angeles (UCLA).

His areas of specialization include radiation therapy physics, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT), image-guided radiotherapy (IGRT), optimization and intensity-modulated radiotherapy, and radiation transport methods. He was named a fellow of the American College of Medical Physics (ACMP) in 2005, the American Association of Physicists in Medicine (AAPM) in 2006, and the American College of Radiology (ACR) in 2013. Dr. Solberg is a licensed medical physicist and is certified in therapeutic radiological physics by the American Board of Radiology. (more...)

 

 
MBBS (Sydney), MRCP (UK), FRCR (UK), PhD

Dr Tho is an Associate Professor at UTAR, Malaysia and Consultant Clinical Oncologist at Beacon Hospital. His prior appointments include Associate Professor of Oncology at University Malaya and Academic Clinical Lecturer at the University of Glasgow.

He completed a PhD in molecular biology as a Cancer Research UK/Royal College of Radiologist Fellow at the Beatson Institute for Cancer Research, Glasgow. He is an investigator and collaborator on numerous clinical trials and has an ongoing interest in Neuro-Oncology, stereotactic radiosurgery and immuno-oncology.